Tatiana A. Karelina

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

A Quantitative Systems Pharmacology Model That Describes Neurofilament Light Dynamics During Alzheimer's Disease Progression.

A Quantitative Systems Pharmacology Model That Describes Neurofilament Light Dynamics During Alzheimer's Disease Progression.

Journal: CPT: pharmacometrics & systems pharmacology
Published: August 06, 2024

Quantitative systems pharmacology model of α-synuclein pathology in Parkinson's disease-like mouse for investigation of passive immunotherapy mechanisms.

Quantitative systems pharmacology model of α-synuclein pathology in Parkinson's disease-like mouse for investigation of passive immunotherapy mechanisms.

Journal: CPT: pharmacometrics & systems pharmacology
Published: February 13, 2024

Hallmarks of neurodegenerative disease: A systems pharmacology perspective.

Hallmarks of neurodegenerative disease: A systems pharmacology perspective.

Journal: CPT: pharmacometrics & systems pharmacology
Published: April 20, 2022

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform.

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform.

Journal: CPT: pharmacometrics & systems pharmacology
Published: December 28, 2020

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies.

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies.

Journal: CPT: pharmacometrics & systems pharmacology
Published: June 01, 2020

Correction: A mathematical model of multisite phosphorylation of tau protein.

Correction: A mathematical model of multisite phosphorylation of tau protein.

Journal: PloS one
Published: March 02, 2018

A mathematical model of multisite phosphorylation of tau protein.

A mathematical model of multisite phosphorylation of tau protein.

Journal: PloS one
Published: October 30, 2017

Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta.

Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta.

Journal: CPT: pharmacometrics & systems pharmacology
Published: January 27, 2017

A Translational Systems Pharmacology Model for Aβ Kinetics in Mouse, Monkey, and Human.

A Translational Systems Pharmacology Model for Aβ Kinetics in Mouse, Monkey, and Human.

Journal: CPT: pharmacometrics & systems pharmacology
Published: July 26, 2016

A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils.

A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils.

Journal: CPT: pharmacometrics & systems pharmacology
Published: July 06, 2016

Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis.

Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis.

Journal: Journal of theoretical biology
Published: August 07, 2014

Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.

Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.

Journal: CPT: pharmacometrics & systems pharmacology
Published: January 02, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026